BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Economides MP, Amit M, Mahale PS, Hosry JJ, Jiang Y, Bharadwaj U, Sturgis EM, Torres HA. Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer. Cancer 2018;124:960-5. [PMID: 29149493 DOI: 10.1002/cncr.31146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Torres HA, Pundhir P, Mallet V. Hepatitis C Virus Infection in Patients With Cancer: Impact on Clinical Trial Enrollment, Selection of Therapy, and Prognosis.Gastroenterology. 2019;157:909-916. [PMID: 30797794 DOI: 10.1053/j.gastro.2019.01.271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
2 McDermott JD, Bowles DW. Epidemiology of Head and Neck Squamous Cell Carcinomas: Impact on Staging and Prevention Strategies. Curr Treat Options Oncol 2019;20:43. [PMID: 31011837 DOI: 10.1007/s11864-019-0650-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
3 Koullias Y, Hammond SP. The Promise of Direct-Acting Antiviral Therapies to Improve Care and Outcomes in Patients With Cancer Who Have Chronic Hepatitis C Infection. J Oncol Pract 2019;15:639-40. [PMID: 31825757 DOI: 10.1200/JOP.19.00664] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Angelidakis G, Sturgis EM, Economides MP, Jiang Y, Torres HA. Chronic hepatitis C virus infection in patients with nonoropharyngeal head and neck cancers. Oral Oncology 2018;85:103-5. [DOI: 10.1016/j.oraloncology.2018.08.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Callander JK, Strohl MP, Knott PD, Park A, Seth R, Heaton CM. Hepatitis C as a Potential Risk Factor for Adverse Surgical Outcomes in Head and Neck Free Tissue Transfer Reconstruction. Facial Plast Surg Aesthet Med 2021. [PMID: 34449263 DOI: 10.1089/fpsam.2021.0082] [Reference Citation Analysis]
6 Torres HA, Lok AS, Suarez-Almazor ME, Warneke CL, Kaseb A, Miller E, Sturgis EM, Foreman JT, Angelidakis G, Ahmed S, Ferrajoli A, Samaniego F, Hawk ET, Hwang JP. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer 2021;29:97-105. [PMID: 32314052 DOI: 10.1007/s00520-020-05456-3] [Reference Citation Analysis]
7 Tang B, Zhu G, Chen C, Zheng S, Pu Y, Xu Y, Huang H, Wang G, Huang D, Liu Y, Zhang X. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma. Laryngoscope 2021;131:1774-81. [PMID: 33592124 DOI: 10.1002/lary.29422] [Reference Citation Analysis]